ALDAGEN
ALDAGEN is a biopharmaceutical company developing proprietary regenerative cell therapies that target significant unmet medical needs. We have four product candidates in clinical trials. Our most advanced product candidate is ALD-101. We are currently conducting a pivotal Phase 3 clinical trial of ALD-101 to evaluate its efficacy in improving umbilical cord blood, or cord blood, transplants used to treat inherited metabolic diseases in pediatric patients. We are also conducting or supporting Phase 1 or Phase 1/2 clinical trials of three other product candidates ALD--151 to improve cord blood transplants used for the treatment of leukemia; ALD-301 to treat critical limb ischemia; and ALD-201 to treat ischemic heart failure.
ALDAGEN
Social Links:
Industry:
Biotechnology Health Care Therapeutics
Founded:
2000-01-01
Address:
Durham, North Carolina, United States
Country:
United States
Website Url:
http://www.aldagen.com
Total Employee:
11+
Status:
Active
Contact:
919-484-2571
Email Addresses:
[email protected]
Total Funding:
64.53 M USD
Technology used in webpage:
Domain Not Resolving Black Lotus NameSilo DNS BuyVM
Current Advisors List
Current Employees Featured
Founder
Investors List
The Aurora Funds
The Aurora Funds investment in Series D - Aldagen
Intersouth Partners
Intersouth Partners investment in Series D - Aldagen
Harbert Growth Partners
Harbert Growth Partners investment in Series D - Aldagen
Tullis Health Investors
Tullis Health Investors investment in Series D - Aldagen
Tullis Health Investors
Tullis Health Investors investment in Series C - Aldagen
Intersouth Partners
Intersouth Partners investment in Series C - Aldagen
Harbert Growth Partners
Harbert Growth Partners investment in Series C - Aldagen
CNF Investments, LLC
CNF Investments, LLC investment in Series C - Aldagen
Piedmont Angel Network
Piedmont Angel Network investment in Series C - Aldagen
The Trelys Funds
The Trelys Funds investment in Series C - Aldagen
Official Site Inspections
http://www.aldagen.com
- Host name: a904c694c05102f30.awsglobalaccelerator.com
- IP address: 76.223.54.146
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
